We are supplier of Cocaine Test Kit. Cocaine Derived from the leaves of coca plant, cocaine is a potent central nervous system stimulant as well as a local anesthetic. Some of the psychological effects induced by cocaine are: euphoria, confidence and a sense of increased energy, accompanied by increased heart rate, dilation of the pupils, fever, tremors and sweating. Continued ingestion of cocaine could induce tolerances and physiological dependency which leads to its abuse. Cocaine is ingested by smoking, intravenous, intranasal or oral administration and excreted in the urine primarily in a short period as benzoylecgonine. Benzoylecgonine has a biological half-life of 5-8 hours, which is much longer than that of cocaine (0.5-1.5 hours), and can be generally detected for 12-72 hours after cocaine is ingested.
Avon Healthcare is engaged in supplying _Barbiturate Test Kit.
_Barbiturates are a group of prescription drugs that are frequently abused. They depress the central nervous system. Acute higher dose induces exhilaration, sedation and respiratory depression. More acute responses produce respiratory collapse and coma. The effects of short acting _barbiturates such as secobarbital last about 3-6 hours. The effects of long acting _barbiturates, such as Phenobarbital, last about 10-20 hours. Short-acting _barbiturates normally remain detectable in urine for 4 to 6 days, while long-acting _barbiturates can be detected for up to 30 days. _Barbiturates are excreted in the urine in unchanged forms, hydroxylated derivatives, carboxylated derivatives and glucuronide conjugates.
Avon Healthcare is enaged in supplying Benzodiazepine Test Kit. .
Benzodiazepines are a class of widely prescribed central nervous system depressants which have anxiolytic, hypnotic, anticonvulsant, and muscle relaxant effects. Chronic abuse can result in addiction and tardive dyskinesia. Acute higher doses lead to drowsiness, dizziness, muscle relaxation, lethargy, coma and possible death. The effects of benzodiazepines use last 4- 8 hours. Many of the benzod.iazepines share a common metabolic route, and are excreted as oxazepam and its glucuronide in urine. Oxazepam is detectable in the urine for up to 7 days after ingestion. Bupren.orphine, a derivative of theb.aine, is an opi.oid that has been marketed in the United States as the Schedule V parenteral analgesic Bupr.enex ®. In 2003, based upon a reevaluation of available evidence regarding the potential for abuse and addiction, the DEA reclassified Bupreno.rphine from a Schedule V to a Schedule III narcotic. Buprenorp.hine resembles mor.phine structurally but has a longer duration of action than morph.ine and can be administrated sublingually as an analgesic.
In October 2002, FDA approved the use of a Buprenorp.hine monotherapy product, Subut.ex ®, and a Buprenorphine/Nalo.xone combination product, Subo.xone ®, for the treatment of opio.id addiction. Subu.tex ® and Suboxon.e ® are the first narcotic drugs available under the US Drug Act (DATA) of 2003 for the treatment of opi.oid dependence that can be prescribed in the US by a licensed physician. It has also been shown that Bupre.norphine has abuse potential and may itself cause dependency. In addition, a number of deaths have been recorded as a result of overdose with intravenously injected Bupreno.rphine in conjunction with other psychotropic drugs such as benzodi.azepines. Buprenorp.hine is metabolized primarily by n-dealkylation to form glucuronide-bupren.orphine and glucuronide-norbupreno.rphine
Avon Healthcare is engaged in supplying Methadone Test Kit.
Methadone is a synthetic opio.id, clinically available. It is used clinically for the treatment of severe pain and in maintenance programs for morp.hine and her.oin addicts. Me.thadone acts on the central nervous and cardiovascular systems to produce respiratory and circulatory depression. Me.thadone also produces miosis and increases the tone of smooth muscle in the lower gastrointestinal tract while decreasing the amplitude of contractions. Acute higher doses induce analgesia, sedation, respiratory depression and coma. After m.ethadone administration, the major urinary excretion products are me.thadone and its metabolites, EDDP and EMDP. Large individual variations in the urine excretion of m.ethadone are output of me.thadone from 5-22%. Typically, following a 5mg oral dose, me.thadone and EDDP account for 5% of the dose in the 24-hour urine. In those individuals on maintenance therapy, met.hadone may account for 5 to 50% of the dose in the 24-hour urine and EDDP may account for 3 to 25% of the dose.
Phencyclidine commonly known as PCP, is an hallucinogen which interacts with dopamine, cholinergic and adrenergic systems. It has dose dependent stimulant, depressant, hallucinogenic and psychological effects. PCP is mostly administered by oral or intravenously. Even a moderate amount of PCP, from 5 to 100 ng/ml, can result in psychotic, violent and selfdestruction. At higher doses, from 100 to 500 ng/ml, PCP can cause convulsions, hypertension, prolonged coma, absent peripheral sensation, and even death. PCP is metabolized via hydroxylation, oxidation, and conjugation with glucuronic acid in the liver. About 10% of the dose is excreted in urine as unchanged drug. PCP can be detected in the urine for 7-8 days after drug administration. For chronic users, PCP may persist in urine for 2-4 weeks. The length of time following drug use for which a positive result may occur is dependent upon several factors, including the frequency and amount of drug, metabolic rate, excretion rate, drug half-life, and the drug user’s age, weight, activity, and diet.
Avon Healthcare is enaged in supplying Buprenorphine (BUP) Test Kit.
(MDMA) Methylenedioxym.ethamph.etamine (Ecs.tasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity. Those who take the drug frequently report adverse effects, such as increased muscle tension and sweating. MD.MA is not clearly a stimulant, although it has, in common with amphe.tamine drugs, a capacity to increase blood pressure and heart rate. MD.MA does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to be via release of the neurotransmitter serotonin. MD.MA may also release dopamine, although the general opinion is that this is a secondary effect of the drug. The most pervasive effect of MD.MA, occurring in almost all people who have taken a reasonable dose of the drug, is to produce a clenching of the jaws. The MD.MA Ecs.tasy Test Strip yields a positive result when .Methylenedioxym.ethamphet.amine in urine exceeds 500ng/ml.
TCA Tricyclic antidepressants (TC.A’s) are a type of prescription drug for the treatment of depressive disorders. Tricyclic Antidepressants consist of two main chemical classes. The tertiary amines boost serotonin levels and are usually prescribed for insomnia, irritability and overstimulation; these include amitryptiline, imipramine and doxepin. The secondary amines which include nortryptiline, desipramine and protriptyline, enhance norepinephrine levels and are prescribed for fatigue; withdrawal and inertness. T.CA abuse can result in respiratory depression. Convulsions, blood pressure deviation, severe cardiac conditions, and coma. TC.A’s are taken orally or sometimes by injection. T.A’s are excreted in the urine mostly in the form of metabolites for up to 10 days. THC The agents of Marijua.na that
Oxycodone is marketed under the brand names Oxyc.ontin ®, Roxico.done ® and is an ingredient of Perco.dan ®, Perc.ocet ® , Roxi.cet ® and Ty.lox ®. Oxyco.done is a semi-synthetic opi.ate derived from opiu.m. Like other opi.ates, Oxycodo.ne is characterized by its analgesic properties, and the tendency for users to develop physical dependency and tolerance with extended use. Oxyco.done is usually administered in combination with non-opia.te analgesics such as acetaminophen and salicylates for the relief of moderate to severe pain. Oxyco.done is a central nervous system depressant that may cause drowsiness, dizziness, lethargy, weakness and confusion. Toxicity in an overdose of Oxyc.odone can lead to stupor, coma, muscle flaccidity, severe respiratory depression, hypotension, and cardiac arrest. Oxyco.done is metabolized by N- and O-demethylation. One of the metabolites, oxymor.phone, is a potent narcotic analgesic, while the other, noroxyco.done, is relatively inactive. Between 33 to 61% of a single dose of Oxyc.odone is excreted in a 24 hour urine collection and consists of 13-19% free ox.ycodone, 7-29% glucuronide conjugated Oxycod.one, 13-14% glucuronide conjugated oxymor.phon.e and an unknown amount of noroxy.codone. The detection window of time for Oxyco.done is 1-3 days following use.
Avon Healthcare is engaged in supplying Drug of Abuse Panel 2 Test Kit.
Avon healthcare is enagaged in suppyling Drug of Abuse Panel 3 Test Kit.
Avon Healthcare is enaged in supplying Drug of Abuse Panel 4 Test Kit.
Avon Healthcare is engaged in supplying Drug of Abuse Panel 5 Test Kit.
Avon Healthcare is engaged in supplying Drug of Abuse Panel 6 Test Kit.
Avon healthcare is engaged in supplying Drug of Abuse Panel 9 Test Kit.